Published April 23, 2020
| Version v1
Patent
Open
METHODS AND COMPOSITIONS FOR TREATING CANCER WITH ECM-AFFINITY PEPTIDES LINKED TO IMMUNOTHERAPEUTIC ANTIBODIES
Creators
- 1. University of Chicago
Contributors
Patent applicant:
Description
The methods and compositions described herein address the need in the art by providing compositions and methods for a therapy with an antibody that is specifically targeted to and/or retained intra- or peri-tumorally, limiting systemic exposure and reducing side-effects. Accordingly, aspects of the disclosure relate to a composition comprising an immunotherapeutic antibody operatively linked to an extracellular matrix (ECM)-affinity peptide. An ECM-affinity peptide is one that has affinity for an extracellular matrix protein.
Files
US20200123228.pdf
Files
(4.8 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:d0c7df7ad53dcf056a5b3ae80f058028
|
4.8 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201816606539 A
- Patent number
- US 2020/0123228 A1
- Other
- oai:uchicago.tind.io:8106
Dates
- Patent filed
-
2018-04-20